Yubo International Biotech Limited Share Price Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Sales 2022 | 0.1 8.21 | Sales 2023 | 0.6 47.61 | Capitalization | 35.95M 2.83B |
---|---|---|---|---|---|
Net income 2022 | -1M -78.74M | Net income 2023 | -1M -78.74M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K 60.81M | Net Debt 2023 | 386K 30.36M | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 31/12/19 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |